151. Analysis of signaling cascades from myeloma cells treated with pristimerin
- Author
-
Almaghrbi, Heba, Elkardawy, Rehab, Kumar. S, Udhaya, Kuttikrishnan, Shilpa, Abunada, Taghreed, Kashyap, Manoj Kumar, Ahmad, Aamir, Uddin, Shahab, Doss. C, George Priya, and Zayed, Hatem
- Subjects
Protein-protein interaction ,Heat shock proteins ,Multiple myeloma ,Microarray ,Functional enrichment analysis ,Pristimerin - Abstract
Multiple myeloma (MM) is the 2nd most frequently diagnosed blood cancer after non-Hodgkin's lymphoma. The present study aimed to identify the differentially expressed genes (DEGs) between the control and pristimerin-treated MM cell lines. We examined the GSE14011 microarray dataset and screened DEGs with GEO2R statistical tool using the inbuilt limma package. We used a bioinformatics pipeline to identify the differential networks, signaling cascades, and the survival of the hub genes. We implemented two different enrichment analysis including ClueGO and Metacore, to get accurate annotation for most significant DEGs. We screened the most significant 408 DEGs from the dataset based on p-values and logFC values. Using protein network analysis, we found the genes UBC, HSP90AB1, HSPH1, HSPA1B, HSPA1L, HSPA6, HSPD1, DNAJB1, HSPE1, DNAJC10, BAG3, and DNAJC7 had higher node degree distribution. In contrast, the functional annotation provided that the DEGs were predominantly enriched in B-cell receptor signaling, unfolded protein response, positive regulation of phagocytosis, HSP70, and HSP40-dependent folding, and ubiquitin-proteasomal proteolysis. Using network algorithms, and comparing enrichment analysis, we found the hub genes enriched were INHBE, UBC, HSPA1A, HSP90AB1, IKBKB, and BAG3. These DEGs were further validated with overall survival and gene expression analysis between the tumor and control groups. Finally, pristimerin effects were validated independently in a cell line model consisting of IM9 and U266 MM cells. Pristimerin induced in vitro cytotoxicity in MM cells in a dose-dependent manner. Pristimerin inhibited NF-?B, induced accumulation of ubiquitinated proteins and inhibited HSP60 in the validation of bioinformatics findings, while pristimerin-induced caspase-3 and PARP cleavage confirmed cell death. Taken together, we found that the identified DEGs were strongly associated with the apoptosis induced in MM cell lines due to pristimerin treatment, and combinatorial therapy derived from pristimerin could act as novel anti-myeloma multifunctional agents. 2022 The fund of APC was provided with the Qatar University grant: QUST-1-CHS-2021-2. The in vitro experiment is supported by a grant from Medical Research Center, Hamad Corporation to SU (MRC-01-18-120). In addition, the authors would like to thank the Vellore Institute of Technology (VIT), Vellore, India, and Qatar University, Qatar for providing the necessary research facilities and encouragement to carry out this work. Scopus
- Published
- 2023